Wolchok JD - Search Results

1

Nivolumab plus ipilimumab in advanced melanoma.

Wolchok JD, Kluger H, Callahan MK, Postow MA, Rizvi NA, Lesokhin AM, Segal NH, Ariyan CE, Gordon RA, Reed K, Burke MM, Caldwell A, Kronenberg SA, Agunwamba BU, Zhang X, Lowy I, Inzunza HD, Feely W, Horak CE, Hong Q, Korman AJ, Wigginton JM, Gupta A, Sznol M. Wolchok JD, et al. N Engl J Med. 2013 Jul 11;369(2):122-33. doi: 10.1056/NEJMoa1302369. Epub 2013 Jun 2. N Engl J Med. 2013. PMID: 23724867 Free PMC article. Clinical Trial.

2

Vaccines and other adjuvant therapies for melanoma.

Wolchok JD, Livingston PO, Houghton AN. Wolchok JD, et al. Hematol Oncol Clin North Am. 1998 Aug;12(4):835-48, vii. doi: 10.1016/s0889-8588(05)70026-5. Hematol Oncol Clin North Am. 1998. PMID: 9759582 Review.

3

Clinical results using biochemotherapy as a standard of care in advanced melanoma.

Chapman PB, Panageas KS, Williams L, Wolchok JD, Livingston PO, Quinn C, Hwu WJ. Chapman PB, et al. Among authors: wolchok jd. Melanoma Res. 2002 Aug;12(4):381-7. doi: 10.1097/00008390-200208000-00011. Melanoma Res. 2002. PMID: 12170188

4

The role of lipopolysaccharide in T-cell responses following DNA vaccination.

Hawkins WG, Trcka J, Segal N, Blachere NE, Gold JS, Moroi Y, Bowne WB, Lewis JJ, Wolchok JD, Houghton AN. Hawkins WG, et al. Among authors: wolchok jd. Vaccine. 2003 Mar 28;21(13-14):1548-53. doi: 10.1016/s0264-410x(02)00676-x. Vaccine. 2003. PMID: 12615452

5

Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial.

Bergman PJ, McKnight J, Novosad A, Charney S, Farrelly J, Craft D, Wulderk M, Jeffers Y, Sadelain M, Hohenhaus AE, Segal N, Gregor P, Engelhorn M, Riviere I, Houghton AN, Wolchok JD. Bergman PJ, et al. Among authors: wolchok jd. Clin Cancer Res. 2003 Apr;9(4):1284-90. Clin Cancer Res. 2003. PMID: 12684396 Clinical Trial.

6

Classification of clear-cell sarcoma as a subtype of melanoma by genomic profiling.

Segal NH, Pavlidis P, Noble WS, Antonescu CR, Viale A, Wesley UV, Busam K, Gallardo H, DeSantis D, Brennan MF, Cordon-Cardo C, Wolchok JD, Houghton AN. Segal NH, et al. Among authors: wolchok jd. J Clin Oncol. 2003 May 1;21(9):1775-81. doi: 10.1200/JCO.2003.10.108. J Clin Oncol. 2003. PMID: 12721254

7

Phase II study of temozolomide plus thalidomide for the treatment of metastatic melanoma.

Hwu WJ, Krown SE, Menell JH, Panageas KS, Merrell J, Lamb LA, Williams LJ, Quinn CJ, Foster T, Chapman PB, Livingston PO, Wolchok JD, Houghton AN. Hwu WJ, et al. Among authors: wolchok jd. J Clin Oncol. 2003 Sep 1;21(17):3351-6. doi: 10.1200/JCO.2003.02.061. J Clin Oncol. 2003. PMID: 12947072 Clinical Trial.

8

Identification of cancer-testis genes expressed by melanoma and soft tissue sarcoma using bioinformatics.

Segal NH, Blachere NE, Guevara-Patiño JA, Gallardo HF, Shiu HY, Viale A, Antonescu CR, Wolchok JD, Houghton AN. Segal NH, et al. Among authors: wolchok jd. Cancer Immun. 2005 Feb 1;5:2. Cancer Immun. 2005. PMID: 15683221

9

Antigens recognized by autologous antibodies of patients with soft tissue sarcoma.

Segal NH, Blachere NE, Shiu HY, Leejee S, Antonescu CR, Lewis JJ, Wolchok JD, Houghton AN. Segal NH, et al. Among authors: wolchok jd. Cancer Immun. 2005 Mar 4;5:4. Cancer Immun. 2005. PMID: 15745419

10

Temozolomide plus thalidomide in patients with brain metastases from melanoma: a phase II study.

Hwu WJ, Lis E, Menell JH, Panageas KS, Lamb LA, Merrell J, Williams LJ, Krown SE, Chapman PB, Livingston PO, Wolchok JD, Houghton AN. Hwu WJ, et al. Among authors: wolchok jd. Cancer. 2005 Jun 15;103(12):2590-7. doi: 10.1002/cncr.21081. Cancer. 2005. PMID: 15861414 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

470 results

Search Page